Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases

被引:37
作者
Kobayashi, Atsushi [1 ]
Kaido, Toshimi [1 ]
Hamaguchi, Yuhei [1 ]
Okumura, Shinya [1 ]
Shirai, Hisaya [1 ]
Kamo, Naoko [1 ]
Yagi, Shintaro [1 ]
Taura, Kojiro [1 ]
Okajima, Hideaki [1 ]
Uemoto, Shinji [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan
关键词
SKELETAL-MUSCLE; EICOSAPENTAENOIC ACID; HEPATIC RESECTION; PROGNOSTIC-FACTOR; TISSUE CONTENT; MASS INDEX; CANCER; SURVIVAL; HEPATECTOMY; MANAGEMENT;
D O I
10.1007/s00268-017-4255-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
We have reported preoperative low skeletal muscularity as an independent risk factor for poor outcomes after liver transplantation, resection of hepatocellular carcinoma, pancreatic cancer and extrahepatic biliary malignancies. However, the impacts of visceral adiposity and muscularity on outcomes after liver resection for colorectal liver metastases (CLM) have not been fully investigated. We retrospectively analyzed 124 patients undergoing primary liver resection for CLM between 2005 and 2014. Using preoperative computed tomography at the third lumbar vertebra level, skeletal muscle and abdominal adipose tissue were evaluated by skeletal muscle index (SMI), intramuscular adipose tissue content (IMAC) and visceral-to-subcutaneous adipose tissue area ratio (VSR), respectively. Impacts of preoperative SMI, IMAC and VSR on outcomes after liver resection for CLM were investigated. Low SMI and high VSR were not significantly associated with poor overall or recurrence-free survivals (P = 0.324 and P = 0.106, P = 0.964 and P = 0.738, respectively). Overall survival rate tended to be lower in patients with high IMAC than in patients with normal IMAC (P = 0.054). Recurrence-free survival rate did not differ significantly between high and normal IMAC (P = 0.721). Multivariate analysis showed that low SMI, high IMAC and high VSR were not significant risk factors for death or recurrence after liver resection for CLM. Neither preoperative visceral adiposity nor low muscularity were poor prognostic factors in patients undergoing liver resection for CLM.
引用
收藏
页码:1180 / 1191
页数:12
相关论文
共 42 条
[1]   Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition [J].
Bahat, Gulistan ;
Tufan, Asli ;
Tufan, Fatih ;
Kilic, Cihan ;
Akpinar, Timur Selcuk ;
Kose, Murat ;
Erten, Nilgun ;
Karan, Mehmet Akif ;
Cruz-Jentoft, Alfonso J. .
CLINICAL NUTRITION, 2016, 35 (06) :1557-1563
[2]   Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival [J].
Beppu, Toru ;
Miyamoto, Yuji ;
Sakamoto, Yasuo ;
Imai, Katsunori ;
Nitta, Hidetoshi ;
Hayashi, Hiromitsu ;
Chikamoto, Akira ;
Watanabe, Masayuki ;
Ishiko, Takatoshi ;
Baba, Hideo .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 :405-413
[3]   Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort [J].
Bijlsma, A. Y. ;
Meskers, C. G. M. ;
Ling, C. H. Y. ;
Narici, M. ;
Kurrle, S. E. ;
Cameron, I. D. ;
Westendorp, R. G. J. ;
Maier, A. B. .
AGE, 2013, 35 (03) :871-881
[4]   Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy [J].
Bismuth, H ;
Adam, R ;
Levi, F ;
Farabos, C ;
Waechter, F ;
Castaing, D ;
Majno, P ;
Engerran, L .
ANNALS OF SURGERY, 1996, 224 (04) :509-520
[5]   Sarcopenia: Current Concepts and Imaging Implications [J].
Boutin, Robert D. ;
Yao, Lawrence ;
Canter, Robert J. ;
Lenchik, Leon .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (03) :W255-W266
[6]   Sarcopenia: European consensus on definition and diagnosis [J].
Cruz-Jentoft, Alfonso J. ;
Baeyens, Jean Pierre ;
Bauer, Juergen M. ;
Boirie, Yves ;
Cederholm, Tommy ;
Landi, Francesco ;
Martin, Finbarr C. ;
Michel, Jean-Pierre ;
Rolland, Yves ;
Schneider, Stephane M. ;
Topinkova, Eva ;
Vandewoude, Maurits ;
Zamboni, Mauro .
AGE AND AGEING, 2010, 39 (04) :412-423
[7]   Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis An International Multi-Institutional Analysis of 1669 Patients [J].
de Jong, Mechteld C. ;
Pulitano, Carlo ;
Ribero, Dario ;
Strub, Jennifer ;
Mentha, Gilles ;
Schulick, Richard D. ;
Choti, Michael A. ;
Aldrighetti, Luca ;
Capussotti, Lorenzo ;
Pawlik, Timothy M. .
ANNALS OF SURGERY, 2009, 250 (03) :440-448
[8]   The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases [J].
Eriksson, Sam ;
Nilsson, Jan H. ;
Holka, Peter Strandberg ;
Eberhard, Jakob ;
Keussen, Inger ;
Sturesson, Christian .
HPB, 2017, 19 (04) :331-337
[9]   Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study) [J].
Folprecht, G. ;
Gruenberger, T. ;
Bechstein, W. ;
Raab, H. -R. ;
Weitz, J. ;
Lordick, F. ;
Hartmann, J. T. ;
Stoehlmacher-Williams, J. ;
Lang, H. ;
Trarbach, T. ;
Liersch, T. ;
Ockert, D. ;
Jaeger, D. ;
Steger, U. ;
Suedhoff, T. ;
Rentsch, A. ;
Koehne, C. -H. .
ANNALS OF ONCOLOGY, 2014, 25 (05) :1018-1025
[10]   Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J].
Folprecht, Gunnar ;
Gruenberger, Thomas ;
Bechstein, Wolf O. ;
Raab, Hans-Rudolf ;
Lordick, Florian ;
Hartmann, Joerg T. ;
Lang, Hauke ;
Frilling, Andrea ;
Stoehlmacher, Jan ;
Weitz, Juergen ;
Konopke, Ralf ;
Stroszczynski, Christian ;
Liersch, Torsten ;
Ockert, Detlev ;
Herrmann, Thomas ;
Goekkurt, Eray ;
Parisi, Fabio ;
Koehne, Claus-Henning .
LANCET ONCOLOGY, 2010, 11 (01) :38-47